TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
NCT07048574
This study is recruiting at 12 US sites in 11 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a longitudinal, observational epidemiological study designed to estimate the prevalence of depression, anxiety, and behavior problems in children ages 18 months through 11 years with cystic fibrosis (CF).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Cystic Fibrosis (CF)
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 months to 11 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- State University of New York at Buffalo
- Last updated on ClinicalTrials.gov
- July 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Children's Hospital of Orange County · Orange, CA
Colorado · 1
- Children's Hospital Colorado · Aurora, CO
Florida · 2
- Joe DiMaggio · Hollywood, FL
- Nemours Foundation · Orlando, FL
Indiana · 1
- Indiana University · Bloomington, IN
Massachusetts · 1
- Massachusetts General Hospital · Boston, MA
New York · 1
- University at Buffalo · Buffalo, NY
North Carolina · 1
- University of North Carolina School of Medicine · Chapel Hill, NC
Ohio · 1
- Cincinnati Children's Hospital Medical Center · Cincinnati, OH
Texas · 1
- UT Southwestern · Plano, TX
Virginia · 1
- Children's Hospital of Richmond at Virginia Commonwealth University · Richmond, VA
Washington · 1
- Seattle Children's Hospital · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.